During the COVID-19 pandemic, lateral flow tests (LFTs) were used to regulate access to work, education, social activities, and travel. However, falsification of home LFT results was a concern.
Lateral flow tests have transformed global healthcare by enabling rapid disease detection and improving access to medical diagnostics. However, their widespread, single-use design is creating an ...
Lateral flow immunoassays (LFIAs) represent a class of paper-based diagnostic devices designed for rapid, on-site detection of specific biomarkers in complex samples. At their core, these assays rely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results